Gianluca Fossati Selected Research

glycyl-(ethyl)lysyl-prolyl-arginine

11/2007

ITF1697, a stable Lys-Pro-containing peptide, inhibits weibel-palade body exocytosis induced by ischemia/reperfusion and pressure elevation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gianluca Fossati Research Topics

Disease

8	Neoplasms (Cancer) 01/2022 - 03/2002
3	Rheumatoid Arthritis 01/2018 - 01/2008
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 12/2019
2	Crohn Disease (Crohn's Disease) 01/2008 - 11/2007
1	Virus Diseases (Viral Diseases) 01/2022
1	Disease Progression 01/2022
1	COVID-19 01/2022
1	Infections 01/2022
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2019
1	Colorectal Neoplasms (Colorectal Cancer) 09/2019
1	Tics (Tic) 09/2019
1	Colonic Neoplasms (Colon Cancer) 09/2019
1	Neoplasm Metastasis (Metastasis) 09/2019
1	Breast Neoplasms (Breast Cancer) 09/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2018
1	Leukemia 01/2018
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2018
1	Gout 03/2016
1	Gouty Arthritis 03/2016
1	Glioblastoma (Glioblastoma Multiforme) 01/2016
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2015
1	Lymphoma (Lymphomas) 03/2015
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2015
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2014
1	Arthritis (Polyarthritis) 05/2011
1	Multiple Myeloma 02/2010
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2008
1	Necrosis 01/2008
1	Endotoxemia 11/2007
1	Ischemia 11/2007
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2006
1	Stroke (Strokes) 12/2006
1	Hepatitis 01/2005
1	Inflammation (Inflammations) 01/2005

Drug/Important Bio-Agent (IBA)

12	Histone Deacetylase InhibitorsIBA 01/2022 - 01/2005
5	CytokinesIBA 01/2022 - 03/2002
5	Histone Deacetylases (Histone Deacetylase)IBA 01/2022 - 03/2002
5	givinostatIBA 01/2021 - 05/2011
5	givinostat hydrochlorideIBA 01/2018 - 01/2005
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2006
2	EnzymesIBA 01/2022 - 01/2022
2	Histone Deacetylase 6IBA 12/2019 - 01/2018
2	Pharmaceutical PreparationsIBA 09/2019 - 02/2010
2	Biological ProductsIBA 09/2019 - 02/2010
2	Histones (Histone)IBA 01/2016 - 12/2006
2	ChromatinIBA 03/2015 - 01/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2008 - 11/2007
1	MethyltransferasesIBA 01/2022
1	VaccinesIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	Protein Isoforms (Isoforms)IBA 12/2019
1	Daunorubicin (Cerubidine)FDA LinkGeneric 09/2019
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 09/2019
1	gonadotropin-releasing hormone-IIIIBA 09/2019
1	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 09/2019
1	trichostatin A (A 300)IBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	theasinensin AIBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	histone deacetylase 3IBA 01/2017
1	Uric Acid (Urate)IBA 03/2016
1	InflammasomesIBA 03/2016
1	MetallothioneinIBA 03/2015
1	Transcription Factors (Transcription Factor)IBA 01/2014
1	Vorinostat FDA Link 01/2014
1	MicroRNAs (MicroRNA)IBA 02/2010
1	Immunoglobulin Fab FragmentsIBA 01/2008
1	Certolizumab Pegol FDA Link 01/2008
1	Complement System Proteins (Complement)IBA 01/2008
1	Peptides (Polypeptides)IBA 11/2007
1	glycyl-(ethyl)lysyl-prolyl-arginineIBA 11/2007
1	lysylprolineIBA 11/2007
1	TransferasesIBA 12/2006
1	Concanavalin AIBA 01/2005

Therapy/Procedure

5	Therapeutics 01/2022 - 12/2006
1	Drug Therapy (Chemotherapy) 01/2022
1	Organ Transplantation 12/2019